STRATTICE Reconstructive Tissue Matrix
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STRATTICE Reconstructive Tissue Matrix, covering 2017-03-16 to 2017-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases [NA]